U.S. AI Spending Nears $1 Trillion, But Industrial Base Stalls

Record AI investment hasn't lifted the broader economy

America's hyperscalers have scaled their research and capital spending fifty-fold over two decades, reaching $750 billion in 2025 compared to just $15 billion in 2005. By the end of 2026, cumulative investment by these technology giants could approach $1 trillion, according to an analysis first reported by TIME.

Yet this extraordinary capital deployment has failed to trigger the industrial renaissance many anticipated. Productive investment—the measure tracking spending on factories, equipment, infrastructure, and intellectual property—has barely moved as a percentage of U.S. GDP. The disconnect reveals a troubling reality: AI's boom remains largely confined to the technology sector rather than reshaping manufacturing capacity across the economy.

Why it matters

Productive investment serves as a leading indicator of where production, jobs, and economic growth will materialize in coming years. While the United States has outperformed most developed economies on investment since the 2008 financial crisis, China is adding roughly $4.4 trillion in net productive assets annually—approximately four times the equivalent U.S. figure. This gap directly threatens American competitiveness and the reshoring ambitions that gained momentum in 2022.

The cost barrier to making in America

Building products domestically comes with substantial cost penalties. Excluding subsidies, manufacturing semiconductors costs roughly 40% more in the United States than in the most competitive global locations, while pharmaceutical production runs 60% higher. Developing a new antibody medicine costs 2.7 times as much compared to China.

Two factors drive most of this gap. First, U.S. construction costs run about double those in Asia, with project timelines stretching twice as long—recent nuclear facilities have taken up to a decade to complete versus six years in China. Second, American labor costs range from two to five times higher than in China or Taiwan. Productivity advantages that once justified this premium have largely evaporated. In advanced semiconductor fabrication facilities, Taiwanese engineers now produce roughly 25% more per worker than their U.S. counterparts, despite earning less than 40% of American wages.

Closing the competitiveness gap

Companies can narrow these disadvantages through operational innovation. Modular, off-site construction methods can halve project timelines and reduce capital costs by 10 to 20%. AI-driven and robotics-first operating models offer pathways to transform labor productivity. Analysis suggests these approaches could close half to two-thirds of the U.S. cost gap.

Where cost parity remains unattainable, manufacturers can compete on service quality, brand strength, customer proximity, and innovation. Complex therapeutics, for instance, command premium margins and benefit from a decade or more of commercial exclusivity. Performance and trust can sustain higher prices, particularly as unrestricted access to the U.S. market grows more valuable.

The policy challenge

Policymakers face difficult triage decisions. Addressing the most critical U.S. import dependencies could require approximately $2 trillion in additional manufacturing investment—roughly 6% of GDP. Investment in factory structures fell 6% at the end of 2025 after peaking in 2024, while spending on general industrial equipment remained essentially flat.

The analysis suggests focusing intervention on the roughly 25% of imported manufactured goods that are critical to national security, exposed to supply concentration, and sourced from geopolitically distant partners. The scale of required intervention—whether through selective trade measures, financial support, or industrial policy—is substantial.

The details were first reported by TIME in their analysis of America's AI investment boom and its limited industrial spillover effects.